Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > BMO take over? Insiders?

<< Previous

Bullboard Posts

Next >>

Comment by Budd22on Jan 17, 2023 4:41pm

148 Views

Post# 35229182

RE:RE:RE:BMO take over? Insiders?

BMO is loading up on shares while existing shareholders are selling to get into the .07 cent PP. BMO will then have a boat load of shares and be the institution to loan VM the $50 million. They will make interest off the $50 million loan plus loading up on shares now for when the price spikes after the loan announcement/ Francis creek production begins.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec